PubMed

The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium.

Quast U, Stephan D, Bieger S, Russ U.

Diabetes. 2004 Dec;53 Suppl 3:S156-64. Review.PMID: 15561904 [PubMed - indexed for MEDLINE]Related articlesFree article

Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.

Stephan D, Winkler M, Kühner P, Russ U, Quast U.

Diabetologia. 2006 Sep;49(9):2039-48. Epub 2006 Jul 25.PMID: 16865362 [PubMed - indexed for MEDLINE]Related articles

The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.

Sunaga Y, Gonoi T, Shibasaki T, Ichikawa K, Kusama H, Yano H, Seino S.

Eur J Pharmacol. 2001 Nov 9;431(1):119-25.PMID: 11716850 [PubMed - indexed for MEDLINE]Related articles

Human ether-a-go-go-related (HERG) gene and ATP-sensitive potassium channels as targets for adverse drug effects.

Zünkler BJ.

Pharmacol Ther. 2006 Oct;112(1):12-37. Epub 2006 May 2. Review.PMID: 16647758 [PubMed - indexed for MEDLINE]Related articles

Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions.

Gribble FM, Reimann F.

J Diabetes Complications. 2003 Mar-Apr;17(2 Suppl):11-5. Review.PMID: 12623163 [PubMed - indexed for MEDLINE]Related articles

Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels.

Geng X, Li L, Bottino R, Balamurugan AN, Bertera S, Densmore E, Su A, Chang Y, Trucco M, Drain P.

Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E293-301. Epub 2007 Apr 3.PMID: 17405830 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibitors of ATP-sensitive potassium channels in guinea pig isolated ischemic hearts.

Weyermann A, Vollert H, Busch AE, Bleich M, Gögelein H.

Naunyn Schmiedebergs Arch Pharmacol. 2004 Apr;369(4):374-81. Epub 2004 Mar 16.PMID: 15024553 [PubMed - indexed for MEDLINE]Related articles

Sulfonylurea and non-sulfonylurea hypoglycemic agents: pharmachological properties and tissue selectivity.

Nagashima K, Takahashi A, Ikeda H, Hamasaki A, Kuwamura N, Yamada Y, Seino Y.

Diabetes Res Clin Pract. 2004 Dec;66 Suppl 1:S75-8. Review.PMID: 15563985 [PubMed - indexed for MEDLINE]Related articles

Insulin secretion and its modulation by antiarrhythmic and sulfonylurea drugs.

Horie M, Ishida-Takahashi A, Ai T, Nishimoto T, Tsuura Y, Ishida H, Seino Y, Sasayama S.

Cardiovasc Res. 1997 Apr;34(1):69-72. Review.PMID: 9217874 [PubMed - indexed for MEDLINE]Related articlesFree article

Potassium channels in the cardiovascular system.

Pogátsa G.

Diabetes Res Clin Pract. 1995 Aug;28 Suppl:S91-8. Review.PMID: 8529523 [PubMed - indexed for MEDLINE]Related articles

Role of K(ATP)(+) channels and adenosine in the control of coronary blood flow during exercise.

Richmond KN, Tune JD, Gorman MW, Feigl EO.

J Appl Physiol. 2000 Aug;89(2):529-36.PMID: 10926635 [PubMed - indexed for MEDLINE]Related articlesFree article

Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.

Misaki N, Mao X, Lin YF, Suga S, Li GH, Liu Q, Chang Y, Wang H, Wakui M, Wu J.

J Pharmacol Exp Ther. 2007 Aug;322(2):871-8. Epub 2007 May 23.PMID: 17522344 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury.

Elrod JW, Harrell M, Flagg TP, Gundewar S, Magnuson MA, Nichols CG, Coetzee WA, Lefer DJ.

Circulation. 2008 Mar 18;117(11):1405-13. Epub 2008 Mar 3. Erratum in: Circulation.2008 May 6;117(18):e332. PMID: 18316485 [PubMed - indexed for MEDLINE]Related articlesFree article

Tissue selectivity of antidiabetic agent nateglinide: study on cardiovascular and beta-cell K(ATP) channels.

Hu S, Wang S, Dunning BE.

J Pharmacol Exp Ther. 1999 Dec;291(3):1372-9.PMID: 10565863 [PubMed - indexed for MEDLINE]Related articlesFree article

A new benzoxazine compound blocks KATP channels in pancreatic beta cells: molecular basis for tissue selectivity in vitro and hypoglycaemic action in vivo.

Rolland JF, Tricarico D, Laghezza A, Loiodice F, Tortorella V, Camerino DC.

Br J Pharmacol. 2006 Dec;149(7):870-9. Epub 2006 Oct 23.PMID: 17057758 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin secretagogues, sulfonylurea receptors and K(ATP) channels.

Bryan J, Crane A, Vila-Carriles WH, Babenko AP, Aguilar-Bryan L.

Curr Pharm Des. 2005;11(21):2699-716. Review.PMID: 16101450 [PubMed - indexed for MEDLINE]Related articles

Tissue-specific effects of sulfonylureas: lessons from studies of cloned K(ATP) channels.

Ashcroft FM, Gribble FM.

J Diabetes Complications. 2000 Jul-Aug;14(4):192-6. Review.PMID: 11004427 [PubMed - indexed for MEDLINE]Related articles

Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.

Winkler M, Stephan D, Bieger S, Kühner P, Wolff F, Quast U.

J Pharmacol Exp Ther. 2007 Aug;322(2):701-8. Epub 2007 May 10.PMID: 17495126 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of in vivo preconditioning by isoflurane on adenosine triphosphate-sensitive potassium channels in the rat heart: lasting modulation of nucleotide sensitivity during early memory period.

Stadnicka A, Marinovic J, Bienengraeber M, Bosnjak ZJ.

Anesthesiology. 2006 Mar;104(3):503-10.PMID: 16508398 [PubMed - indexed for MEDLINE]Related articlesFree article

Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.

Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, Slingerland AS, Shield J, Robert JJ, Holst JJ, Clark PM, Ellard S, Søvik O, Polak M, Hattersley AT; Neonatal Diabetes International Collaborative Group.

N Engl J Med. 2006 Aug 3;355(5):467-77.PMID: 16885550 [PubMed - indexed for MEDLINE]Related articlesFree article